FDA clears AI-powered digital test for early dementiaThe FDA has approved an artificial intelligence-based test for early detection of dementia that can be carried out Share XFDA clears AI-powered digital test for early dementiahttps://pharmaphorum.com/news/fda-clears-ai-powered-digital-test-for-early-dementia/
UCB licenses AI tech for spinal fracture detection to ImageBiopsyAn artificial intelligence-based tool for identifying hard-to-detect spinal fractures, developed by Belgian drugmaker UCB, has been licensed out Share XUCB licenses AI tech for spinal fracture detection to ImageBiopsyhttps://pharmaphorum.com/news/ucb-licenses-ai-tech-for-spinal-fracture-detection-to-imagebiopsy/
Eisai-backed trial will assess Altoida’s digital test for early Alzheimer’sA software platform developed by Altoida that uses augmented reality and artificial intelligence to diagnose neurological diseases in Share XEisai-backed trial will assess Altoida’s digital test for early Alzheimer’shttps://pharmaphorum.com/news/eisai-backed-trial-will-assess-altoidas-digital-test-for-early-alzheimers/
Use of digital tools for clinical trials triples during pandemic; surveyA new poll of clinical trial sponsors has found that around nine out of 10 of them are Share XUse of digital tools for clinical trials triples during pandemic; surveyhttps://pharmaphorum.com/news/use-of-digital-tools-for-clinical-trials-triples-during-pandemic-survey/
UK hospital will use MindMaze game to aid stroke recoveryA hospital trust has become the first in the UK to deploy a gaming system developed by Swiss Share XUK hospital will use MindMaze game to aid stroke recoveryhttps://pharmaphorum.com/news/uk-hospital-will-use-mindmaze-game-to-aid-stroke-recovery/
Headspace and Ginger finalise $3bn digital mental health mergerHeadspace and Ginger have completed their $3 billion combination to create Headspace Health, a new frontrunner in the Share XHeadspace and Ginger finalise $3bn digital mental health mergerhttps://pharmaphorum.com/news/headspace-and-ginger-finalise-3bn-digital-mental-health-merger/
Digital therapeutics world first for Big Health in ScotlandUK-based Big Health has passed a digital health milestone after Scotland became the first country to make anxiety Share XDigital therapeutics world first for Big Health in Scotlandhttps://pharmaphorum.com/news/digital-therapeutics-world-first-big-health-scotland/
Alnylam launches digital tool for ATTR amyloidosis patientsAlnylam has been a pioneer in hereditary ATTR amyloidosis, getting approval in 2018 for the first drug to Share XAlnylam launches digital tool for ATTR amyloidosis patientshttps://pharmaphorum.com/news/alnylam-launches-digital-tool-for-aatr-amyloidosis-patients/
Data dive finds cheap diuretic could be Alzheimer’s drugA data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have Share XData dive finds cheap diuretic could be Alzheimer’s drughttps://pharmaphorum.com/news/data-dive-finds-cheap-diuretic-could-be-alzheimers-drug/
Limbix’ digital therapeutic cuts depression symptoms in young peopleLimbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for Share XLimbix’ digital therapeutic cuts depression symptoms in young peoplehttps://pharmaphorum.com/news/limbix-digital-therapeutic-cuts-depression-symptoms-in-young-people/
Twin Health raises $140m for “digital twin” diabetes reversal appThe developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases Share XTwin Health raises $140m for “digital twin” diabetes reversal apphttps://pharmaphorum.com/news/twin-health-raises-140m-for-digital-twin-diabetes-reversal-app/
SOM’s AI-discovered drug shows promise in Huntington’s diseaseA drug originally developed for high blood pressure could find a new use in the treatment of Huntington’s Share XSOM’s AI-discovered drug shows promise in Huntington’s diseasehttps://pharmaphorum.com/news/soms-ai-discovered-drug-shows-promise-in-huntingtons-disease/
AI specialist Exscientia raises $510m in upsized IPO, placingExscientia’s artificial intelligence-based drug discovery engine is still largely unproven, but that hasn’t stopped the company raking in Share XAI specialist Exscientia raises $510m in upsized IPO, placinghttps://pharmaphorum.com/news/ai-specialist-exscientia-raises-510m-in-upsized-ipo-placing/
Sonde says vocal biomarker tech could detect mental healthSonde Health has launched a new version of its vocal biomarker technology – which aims to diagnose diseases Share XSonde says vocal biomarker tech could detect mental healthhttps://pharmaphorum.com/news/sonde-says-vocal-biomarker-tech-could-detect-mental-health/
Electrical implant treats severe depression in US patientResearchers in the US have successfully treated a patient with severe depression via the use of an implant Share XElectrical implant treats severe depression in US patienthttps://pharmaphorum.com/news/electrical-implant-treats-severe-depression-in-us-patient/
NHSX backs 14 digital health projects after funding roundNHSX, the government agency tasked with digitally transforming NHS England, has granted funding to 14 projects in its Share XNHSX backs 14 digital health projects after funding roundhttps://pharmaphorum.com/news/nhsx-backs-14-digital-health-projects-after-funding-round/
Digital surgery firm Activ raises $45m for AR softwareActiv Surgical has raised $45 million in second-round financing to help develop its augmented reality (AR) based software, Share XDigital surgery firm Activ raises $45m for AR softwarehttps://pharmaphorum.com/news/digital-surgery-firm-activ-raises-45m-for-augmented-reality-software/
Bayer teams up with Huma to apply AI to lung cancer diagnosisA research project between Bayer and digital health company Huma will use artificial intelligence to detect lung cancer Share XBayer teams up with Huma to apply AI to lung cancer diagnosishttps://pharmaphorum.com/news/bayer-teams-up-with-huma-to-apply-ai-to-lung-cancer-diagnosis/
